Sponsored by: Fujifilm

MRI: Page 345

C-11 choline PET/MRI helps restage prostate cancer patients
By Wayne Forrest
A preliminary study by German researchers suggests that carbon-11 (C-11) choline PET/MRI may provide an alternative imaging modality to PET/CT for restaging of prostate cancer by offering equal, if not better, diagnostic performance and less radiation exposure.
December 25, 2012
MRI software predicts stroke complications from clot busters
By Wayne Forrest
Researchers from Johns Hopkins University have developed new MRI software that may help predict and reduce the risk of complications from clot-dissolving drugs used to treat stroke, according to a study published online December 20 in PLOS One.
December 19, 2012
Contrast-enhanced FFDM may have edge over breast MRI
By Kate Madden Yee
Dual-energy contrast-enhanced full-field digital mammography (FFDM) finds additional cancers in the breast with better specificity than MRI, according to a new study published online in Radiology. The findings suggest that contrast mammography could be a feasible alternative to more expensive breast MRI scans.
December 16, 2012
2012 12 13 12 22 21 978 Jochelson 2a Thumb
DTI-MRI shows concussions' long-term effects in kids
By AuntMinnie.com staff writers
Diffusion-tensor MRI (DTI-MRI) has shown that brain changes in children who have sustained mild traumatic brain injury can last for months, even after symptoms of the injury are gone, according to a study published in the December 12 issue of the Journal of Neuroscience.
December 11, 2012
Medical Metrics signs on for FDA hip implant study
By AuntMinnie.com staff writers
Imaging core lab services provider Medical Metrics said it has been selected by five orthopedic device manufacturers to support multiple cross-sectional postmarket surveillance studies of metal-on-metal hip implants.
December 11, 2012
ASRT doles out fall 2012 grants
By AuntMinnie.com staff writers
The American Society of Radiologic Technologists (ASRT) Education and Research Foundation has announced the five recipients of its fall 2012 professional research grants.
December 10, 2012
Fused MRI, ultrasound aids prostate cancer detection
By AuntMinnie.com staff writers
Fusing MR and real-time ultrasound images to sample tumor spots can help detect and diagnose prostate cancer and, as a result, reduce the number of prostate biopsies, according to a study published online December 10 in the Journal of Urology.
December 10, 2012
Sky Factory highlights Texas Tech research
By AuntMinnie.com staff writers
Virtual background developer Sky Factory said that research conducted at Texas Tech University has discovered several unique neural brain activations in the cerebellum of subjects responding to sky images from its SkyCeilings virtual skylights for MRI scanners.
December 10, 2012
Adding MRI and PET to biomarkers helps predict Alzheimer's
By Wayne Forrest
The combination of 1.5-tesla MRI, FDG-PET, and cerebrospinal fluid data when added to routine clinical tests significantly increases the ability to predict whether people with mild cognitive impairment will progress to Alzheimer's disease, according to a study published online December 11 in Radiology.
December 10, 2012
2012 12 11 10 07 12 730 Shaffer Mri Pet Alz Thumb
Diagnosoft, Johns Hopkins win NIH grant
By AuntMinnie.com staff writers
Image analysis software firm Diagnosoft, in partnership with Johns Hopkins University, was awarded a $1 million phase I and II Fast-Track Small Business Innovation Research grant from the National Institutes of Health (NIH) to develop a novel breast tissue stiffness quantification method utilizing MRI.
December 6, 2012
CoreLab adds new imaging service
By AuntMinnie.com staff writers
CoreLab Partners has launched a new imaging service targeting the utilization of independent central image review in the detection of early Alzheimer's disease.
December 5, 2012
Contrast MRI can predict glioblastoma outcomes
By AuntMinnie.com staff writers
Changes in tumor enhancement on postgadolinium T1-weighted MRI scans are highly predictive of which patients with recurrent glioblastoma will benefit from second-line therapy that includes the antiangiogenic drug bevacizumab, according to a study presented last week at the RSNA 2012 conference.
December 3, 2012
Previous Page
Page 345 of 628
Next Page